Product: EIAgen SARS-CoV-2 Kits
Subject: Release

We are pleased to inform you that as of today we are offering a new and improved Vitamin D kit that replaces the previous kit version
and that offers a number of advances and advantages.

Adaltis S.r.l. as a pioneer in ELISA assay development and microplate automation, presents three novel antibody assays for IgA, IgM and IgG ELISA microplate assays to detect the exposure to the SARS-CoV-2 virus. These in-vitro diagnostic assays are designed for manual to fully automated diagnosis of a Covid-19 infection in human beings.

The EIAgen SARS-CoV-2 assays are a perfect addition for SARS-CoV-2 detection done via molecular diagnostic techniques, and can serve as an essential methodology for epidemiological Covid-19 studies.

SARS-CoV-2 ELISA features & benefits:

- Separate detection of IgA, IgM, IgG

- Incubation below 2 hours

- Easy automation on a large range of automated microplate processors

- CE-IVD certified assay

Automation of EIAgen SARS-CoV-2 ELISA testing

With the iconic Personal LAB and NEXgen fully automated microplate processors you facilitate ease of automation with the EIAgen SARS-CoV-2 ELISA’s.

The three different antibody assays can be processed single or combined according to your needs in a range of varieties like IgM + IgG, IgA single, IgA + IgM + IgG, etc.

The EIAgen SARS-CoV-2 ELISA’s are validated applications on Personal LAB (2 microplate) and NEXgen (7 microplate), and provide you an instant start and trouble-free Covid-19 diagnostic testing routine. The EIAgen SARS-CoV-2 ELISA’s run seamlessly on Personal LAB and NEXgen, and provide you cost efficient and reliable test results.

Please products information click here.

For any further information please contact via email at covid19@adaltis.net

If you have any question please, contact our Sales Department via email at sales@adaltis.net.
We will be pleased to be at your service.